Non‑conventional fotemustine schedule as second‑line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
Affiliations: Department of Radiological, Oncological and Anatomo‑Pathological Sciences, ‘Sapienza’ University of Rome, Policlinico Umberto I, I‑00161 Rome, Italy, Department of Medical Oncology, Ospedale Policlinico San Martino IST, University of Genoa, I‑16132 Genoa, Italy, Neurosurgery Department, IRCCS NEUROMED INM, Neurochirurgia, I‑86077 Pozzilli, Italy, Department of Neurology and Psychiatry ‘Sapienza’ University of Rome, Policlinico Umberto I, I‑00161 Rome, Italy, Department of Public Health and Infectious Diseases, ‘Sapienza’ University of Rome, I‑00185 Rome, Italy
- Published online on: October 16, 2018 https://doi.org/10.3892/mco.2018.1746
- Pages: 58-66
Copyright: © Prelaj et al. This is an open access article distributed under the terms of Creative Commons Attribution License.